ClinicalThought

Share

Program Content

Activities

  • Breakthrough Infections and Rebound
    New Data on COVID-19 Treatment and Risk Factors for Severe Breakthrough Infections Post Vaccination
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: November 17, 2022

  • Prophylaxis, Treatment, and Opportunistic Infections
    Interpreting COVID-19 Data From IDWeek 2022: Prophylaxis, Treatment, and Opportunistic Infections in Immunocompromised Individuals
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: November 17, 2022

Provided by

ProCE Banner

Supporters

AstraZeneca

Gilead Sciences, Inc.

Merck Sharp & Dohme Corp.